2
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Leukemia, Myeloid, Acute
125
Myelodysplastic Syndromes
120
Precursor Cell Lymphoblastic Leukemia-Lymphoma
107
Leukemia
86
Hodgkin Disease
81
Leukemia, Lymphocytic, Chronic, B-Cell
78
Lymphoma
76
Multiple Myeloma
75
Lymphoma, Non-Hodgkin
75
Myeloproliferative Disorders
57
Graft vs Host Disease
55
Lymphoma, Follicular
54
Lymphoma, Mantle-Cell
50
Lymphoma, Large B-Cell, Diffuse
50
Leukemia, Myeloid, Accelerated Phase
50
Leukemia, Myelomonocytic, Chronic
48
Congenital Abnormalities
48
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
47
Hematologic Neoplasms
45
Lymphoma, B-Cell, Marginal Zone
44
Leukemia, Myeloid, Chronic-Phase
44
Burkitt Lymphoma
42
Primary Myelofibrosis
41
Blast Crisis
39
Neoplasms, Plasma Cell
38
Lymphoma, Large-Cell, Immunoblastic
34
Waldenstrom Macroglobulinemia
26
Myelodysplastic-Myeloproliferative Diseases
25
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative
25
Anemia, Refractory, with Excess of Blasts
24
Interventions
Mitomycin
3
Hyperthermic Intraperitoneal Chemotherapy
3
Surveys and Questionnaires
2
Oxaliplatin
2
Leucovorin
2
Fluorouracil
2
Capecitabine
2
Bromelains
2
Acetylcysteine
2
tislelizumab
1
molgramostim
1
irinotecan sucrosofate
1
cryoprecipitate coagulum
1
Tacrolimus
1
Standard of Care
1
Specimen Handling
1
Sirolimus
1
Referral and Consultation
1
Radiosurgery
1
Psychiatric Rehabilitation
1
Pharmacogenomic Testing
1
Observation
1
Nivolumab
1
Methods
1
Magnetic Resonance Spectroscopy
1
Lansoprazole
1
Ipilimumab
1
Ifosfamide
1
Gemcitabine
1
Floxuridine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Pseudomyxoma Peritonei
×
Tacrolimus
×
Clear all
NCT06084780
2026-06-05
TRANSCAPE
Case Comprehensive Cancer Center
Phase 2
Not yet recruiting
20 enrolled